Cowealth Medical China Co.,Ltd. (SHA:603122)
China · Delayed Price · Currency is CNY 16.30
+0.14 (0.87%)
At close: Mar 18, 2026
Cowealth Medical China Market Cap
Cowealth Medical China has a market cap or net worth of 6.49 billion as of March 18, 2026. Its market cap has increased by 121.17% in one year.
Market Cap
6.49B
Enterprise Value
6.44B
Revenue
677.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.30
Market Cap Chart
Since February 16, 2022, Cowealth Medical China's market cap has increased from 2.40B to 6.49B, an increase of 170.32%. That is a compound annual growth rate of 27.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 6.43B | -33.77% |
| Dec 31, 2025 | 9.71B | 248.07% |
| Dec 31, 2024 | 2.79B | -12.92% |
| Dec 29, 2023 | 3.20B | -28.13% |
| Dec 30, 2022 | 4.46B | 85.74% |
| Feb 16, 2022 | 2.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dian Diagnostics Group | 12.25B |
| Shanghai Runda Medical Technology | 8.80B |
| Amoy Diagnostics | 8.17B |
| Beijing Strong Biotechnologies,Inc. | 7.34B |
| Maccura Biotechnology Co.Ltd | 6.93B |
| Thalys Medical Technology Group | 5.01B |
| SMO ClinPlus CO.,LTD. | 4.90B |
| Guangdong Hybribio Biotech | 4.16B |